We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+34.93%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$132M
AUM Growth
+$31.8M
Cap. Flow
+$10.8M
Cap. Flow %
8.18%
Top 10 Hldgs %
55.55%
Holding
79
New
8
Increased
18
Reduced
14
Closed
10

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$5.63M
2
CMPX icon
Compass Therapeutics
CMPX
+$2.76M
3
FOLD
Amicus Therapeutics
FOLD
+$1.6M
4
BCYC
Bicycle Therapeutics
BCYC
+$1.16M
5
GPCR icon
Structure Therapeutics
GPCR
+$837K

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$1.13M
2
ELUT icon
Elutia
ELUT
+$830K
3
HROW icon
Harrow
HROW
+$753K
4
AXGN icon
Axogen
AXGN
+$608K
5
XNCR icon
Xencor
XNCR
+$550K

Sector Composition

Rank Sector Weight
1 Healthcare 76.79%
2 Technology 17.82%
3 Energy 4.7%
4 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NPCE icon
76
Neuropace
NPCE
$542M
– –
-16,442
Closed -$183K
TXG icon
77
10x Genomics
TXG
$5.49B
– –
-22,000
Closed -$255K
WVE icon
78
Wave Life Sciences
WVE
$1.11B
– –
-40,300
Closed -$262K
XNCR icon
79
Xencor
XNCR
$1.41B
– –
-70,000
Closed -$550K
1 2 3
4

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Birchview Capital held 79 positions worth $132M, up 32% from $101M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Birchview Capital deployed $10.8M of net new capital in Q3 2025, opening 8 new positions and adding to 18 existing holdings. Its largest new stake was Compass Therapeutics: 872,938 shares worth $3.06M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 79% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $1.13M trimmed.

  • Birchview Capital's largest Q3 2025 buy was Compass Therapeutics: 872,938 shares worth $3.06M.
  • Birchview Capital added most to KLA in Q3 2025, an estimated $5.63M increase.
  • Birchview Capital's biggest Q3 2025 reduction was Travere Therapeutics, cutting an estimated $1.13M.
  • Birchview Capital fully exited Xencor in Q3 2025, selling an estimated $550K.
  • Birchview Capital's ten largest holdings make up 56% of its $132M portfolio in Q3 2025.
  • Birchview Capital opened 8 new positions and closed 10 in Q3 2025.
  • Birchview Capital's portfolio value rose 32% quarter-over-quarter to $132M.

Based on Birchview Capital's 13F filing for Q3 2025, filed 13 Nov 2025.